Neurocrine Biosciences (NBIX) Price to Book (2009 - 2026)
Neurocrine Biosciences' Price to Book came in at 3.70 for Q3 2026, down 20.5% from 4.66 a year earlier and down 20.1% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Price to Book (2009 - 2026) Analysis & Trends
For FY2025, Neurocrine Biosciences' Price to Book was 4.36, down 16.7% from FY2024.
- Price to Book has declined in each of the last three years.
- Going back by year, Price to Book was 5.24 in FY2024 (-10.1%), 5.83 in FY2023 (-13.7%), 6.75 in FY2022 (+14.7%) and 5.88 in FY2021 (-26.1%).
- The Q3 2026 figure represents the lowest quarterly Price to Book since Q4 2012.
- Year-over-year, Price to Book increased in two of the last eight quarters, with an average decline of 11.3%.
- The fastest year-over-year change in Price to Book over five years came in Q4 2022 (growth of 14.7%), and the weakest in Q4 2021 (a decline of 26.1%).
- Business Quant data shows NBIX's Price to Book at 4.64 (Q2 2026), 3.89 (Q1 2026) and 4.36 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.70 |
| Jun 30, 2026 | 4.64 |
| Mar 31, 2026 | 3.89 |
| Dec 31, 2025 | 4.36 |
| Sep 30, 2025 | 4.66 |
| Jun 30, 2025 | 4.62 |
| Mar 31, 2025 | 4.32 |
| Dec 31, 2024 | 5.24 |
| Sep 30, 2024 | 4.29 |
| Jun 30, 2024 | 5.54 |
| Mar 31, 2024 | 5.81 |
| Dec 31, 2023 | 5.83 |
| Sep 30, 2023 | 5.52 |
| Jun 30, 2023 | 4.97 |
| Mar 31, 2023 | 5.86 |
| Dec 31, 2022 | 6.75 |
| Sep 30, 2022 | 6.61 |
| Jun 30, 2022 | 6.55 |
| Mar 31, 2022 | 6.44 |
| Dec 31, 2021 | 5.88 |
API Access
Neurocrine Biosciences Price to Book API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-book&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-book", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-book&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();